Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Life Threatening Gastrointestinal Tumour More Common Than Suspected

22.10.2002


The incidence of gastrointestinal stromal tumours (GISTs), generally considered a rare sarcoma, is more than three times as high as previously believed, according to data presented in Nice at the 27th annual European Society of Medical Oncology (ESMO) Congress. An accurate estimate of GIST incidence has been elusive because of diagnostic ambiguities, now largely resolved by modern immunohistochemistry.



The higher incidence of GIST – calculated at 16 per 1,000,000 people annually – is especially significant because there is now an effective treatment for GIST, the oral therapy imatinib, formerly known as STI 571. The availability of an effective therapy makes it vital to accurately diagnose the disease.

The study, the first population-based examination of the incidence of GIST, was presented by a team headed by Lars-Gunnar Kindblom, MD, PhD, of Sahlgrenska Academy at Göteborg University, Sweden. The team analyzed the medical records and tissue blocks of patients seen from 1983 to 2000 and found 400 cases of true GIST. This was more than three times as many as originally diagnosed. The reanalysis relied in large part on CD 117 (Kit) immunohistochemistry, which Dr. Kindblom pioneered over the past three years. He recommended wider use of CD 117 (Kit) staining for gastrointestinal tumours. Kit receptors in these tumours are the telltale signs of GIST.


“GIST is much more common than we thought, and it is crucial to get the diagnosis right,” Dr. Kindblom said. “Surgeons and pathologists should know that GIST incidence is greater than they had suspected. There is striking variability in the appearance of these tumours, and CD 117 stains for Kit receptors should be widely applied to provide physicians and patients with the best tumour-specific diagnoses, leading to targeted therapeutic options.”

Dr. Kindblom noted that many of the patients in his team’s population-based study who are still living have become candidates for treatment with imatinib.

Historically, GIST has been extremely difficult to treat because of its resistance to treatment with chemotherapy and radiation therapy; surgery to remove GISTs is considered palliative. Imatinib is a targeted treatment for Kit-positive GIST. Imatinib was approved in May 2002 in the European Union, and is also available in many other countries worldwide for the treatment of patients with Kit (CD 117)-positive unresectable (inoperable) and/or metastatic malignant GISTs. An annual incidence of 16 per 1,000,000 means nearly 1,000 new GIST cases per year in France, or about 4,000 new cases per year in the U.S.

The study owes its existence not only to the recent development of CD 117 staining for Kit receptors by Dr. Kindblom but also to the organization of the medical system in southwestern Sweden, where 1.5 million people live. In that part of Sweden, all histology analyses of sarcomas are done in just four laboratories, making their reanalyses manageable.

Carina Elmäng | alfa
Further information:
http://www.sahlgrenska.gu.se/

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>